HDAC8 expression is associated with improved survival in melanoma, but HDAC1 and HDAC8 also correlate with increase phosphorylated p65—a subunit of the NF-κB complex, which is associated with resistance to MAPK inhibitors [36,37]. The gene discussed is HDAC8; the disease is melanoma.